Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
The Oncologist|May 26, 2026
Patient-Specific 3D-Printed HDR Surface Brachytherapy for Basal Cell Carcinoma in Older Patients: Prospective Feasibility and Imaging ResponsePiotr Sobolewski, Mateusz Koper, Michal Poltorak, et al.
Current Issues in Molecular Biology|September 27, 2024
The Role of Caspases in Melanoma PathogenesisAgnieszka Szmurło, Klaudia Dopytalska, Michał Szczerba, et al.
Mikrochimica Acta|May 21, 2026
Detection of bilirubin by stripping voltammetry at the gelled anisole - aqueous electrified interface supported with a 3D printed poreKarolina Marciniak, Konrad Rudnicki, Karolina Kowalewska, et al.
Biosensors & Bioelectronics|November 1, 2025
Reduced graphene oxide modified screen-printed electrode with bioengineered surface for voltammetric detection of prostate-specific antigen in oncological urine samplesMohammad Rizwan, Diana M Bobrowska, Michał Półtorak, et al.
The Journal of Dermatological Treatment|December 15, 2020
The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapyPiotr Ciechanowicz, Klaudia Dopytalska, Agata Mikucka-Wituszyńska, et al.
Dermatologic Therapy|April 1, 2022
Comparative effectiveness of adalimumab versus ustekinumab in the treatment of severe chronic plaque psoriasis: The results based on data from the program "treatment of moderate and severe forms of plaque psoriasis (B.47)" of the National Health Fund in PolandWitold Owczarek, Agnieszka Nowakowska, Irena Walecka, et al.
Reumatologia|September 25, 2019
Systemic sclerosis - multidisciplinary disease: clinical features and treatmentPiotr Sobolewski, Maria Maślińska, Marta Wieczorek, et al.
Postepy Dermatologii I Alergologii|September 12, 2022
Effectiveness of infliximab biosimilars in the treatment of moderate to severe chronic plaque psoriasis: experience of real-world data from the register of the program "Treatment of moderate and severe forms of plaque psoriasis (B.47)" of the National Health Fund in PolandWitold Owczarek, Irena Walecka, Agnieszka Nowakowska, et al.
International Journal of Molecular Sciences|July 15, 2026
APOA1, DEFB103A_DEFB103B and DSG3 Are Novel Circulating Biomarkers of PsoriasisMonika Dźwigała, Dorota Sys, Joanna Życka-Krzesińska, et al.
Biomed Research International|March 19, 2020
NOTCH3 T6746C and TP53 P72R Polymorphisms Are Associated with the Susceptibility to Diffuse Cutaneous Systemic SclerosisSzymon Zmorzyński, Magdalena Wojcierowska-Litwin, Małgorzata Kowal, et al.
Pageof 9